C
FLNA

Covestor’s Filana Therapeutics FLNA Stock Holding History

Covestor’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-28
Closed – – 2712
2025
Q4 		$0 Hold
28
– – ﹤0.01% 2680
2025
Q3 		$0 Hold
28
– – ﹤0.01% 2707
2025
Q2 		$0 Sell
28
-2
-7% -$4 ﹤0.01% 2683
2025
Q1 		$0 Buy
30
+26
+650% +$66 ﹤0.01% 2666
2024
Q4 		$0 Sell
4
-4
-50% -$70 ﹤0.01% 2674
2024
Q3 		$0 Buy
8
+5
+167% +$115 ﹤0.01% 2690
2024
Q2 		$0 Hold
3
– – ﹤0.01% 2686
2024
Q1 		$0 Sell
3
-1
-25% -$23 ﹤0.01% 2669
2023
Q4 		$0 Hold
4
– – ﹤0.01% 2642
2023
Q3 		$0 Sell
4
-1
-20% -$20 ﹤0.01% 2633
2023
Q2 		$0 Hold
5
– – ﹤0.01% 2581
2023
Q1 		$0 Hold
5
– – ﹤0.01% 2507
2022
Q4 		$0 Hold
5
– – ﹤0.01% 2527
2022
Q3 		$0 Sell
5
-1
-17% -$27 ﹤0.01% 2511
2022
Q2 		$0 Sell
6
-2
-25% -$51 ﹤0.01% 2306
2022
Q1 		$0 Sell
8
-3
-27% -$127 ﹤0.01% 2405
2021
Q4 		$0 Buy
+11
New +$577 ﹤0.01% 2282

Other funds holding FLNA

Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Covestor's FLNA Position: Q1 2026 in Review

Covestor sold out of Filana Therapeutics (FLNA) in Q1 2026, closing a stake of 28 shares.

Covestor first reported a position in FLNA in Q4 2021 and held it in 17 quarters. The position peaked at $0 in Q4 2025. 101 funds tracked by Wall St. Rank hold FLNA as of Q1 2026.

  • Covestor reported no remaining Filana Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Covestor sold 28 Filana Therapeutics shares in Q1 2026.
  • Covestor first reported a position in Filana Therapeutics in Q4 2021 and held it in 17 quarters.
  • Covestor's Filana Therapeutics position peaked at $0 in Q4 2025.
  • 101 funds tracked by Wall St. Rank held Filana Therapeutics as of Q1 2026.

Based on Covestor's 13F filing for Q1 2026, filed 5 May 2026.